Identification of Proteomic Markers in Head and Neck Cancer Using MALDI-MS Imaging, LC-MS/MS, and Immunohistochemistry.
Franziska HoffmannClaudia UmbreitThomas KrügerDaniela PelzelGünther ErnstOlaf KniemeyerOrlando Guntinas-LichiusAlexander BerndtFerdinand von EggelingPublished in: Proteomics. Clinical applications (2018)
The combination of MALDI-MSI, LC-MS/MS, and subsequent IHC furnishes a tool suitable for characterizing the molecular heterogeneity of tissue. It is also suited for use in identifying new representative biomarkers to enable a more individualized therapy.